Entities / Company
Gossamer Bio (United States).
company in San Diego, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 24
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
Leerink partners maintained a Buy rating on Gossamer Bio stock on August 19, 2025, citing strategic partnerships and potential benefits from Trump-era tariffs.Some support1 report
-
Gossamer Bio shares surged 139.9% on August 6, 2025, significantly outperforming the S&P 500's 7.6% gain.Some support1 report
-
Institutional investors acquired a large stake in Gossamer Bio, a company based in the United States.Some support1 report
-
Gossamer Bio's revenue is expected to perform substantially worse than the wider industry.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 2 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Chiesi Operational
Gossamer Bio and Chiesi maintain a strategic partnership involving joint development and financial collaboration.
-
Chiesi (United Kingdom) Operational
Gossamer Bio and Chiesi are engaged in a global collaboration to jointly develop seralutinib.
History
Events by the month they beganJune 2026
5 events- Gossamer Bio and Chiesi announced a joint collaboration to develop seralutinib under global collaboration.
- Leerink partners maintained a Buy rating on Gossamer Bio stock on August 19, 2025, citing strategic partnerships and potential benefits from Trump-era tariffs.
- Gossamer Bio shares surged 139.9% on August 6, 2025, significantly outperforming the S&P 500's 7.6% gain.
- Institutional investors acquired a large stake in Gossamer Bio, a company based in the United States.
- Gossamer Bio's revenue is expected to perform substantially worse than the wider industry.